Stephanie Okey - Insider Trading & Ownership

Entity
Individual
Location
C/O Albireo Pharma, Inc., 10 Post Office Square, Suite 502 South, Boston, MA
Summary
The estimated net worth of Stephanie Okey is at least $1.74M dollars as of November 1, 2024. Stephanie Okey is the Director of Catalent, Inc. and owns shares of Catalent, Inc. (CTLT) stock worth about $758K. Stephanie Okey is the Director of PTC THERAPEUTICS, INC. and owns shares of PTC THERAPEUTICS, INC. (PTCT) stock worth about $539K. Stephanie Okey is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446K.
All Insider Reports
All Insider Reports

Ownership of Stephanie Okey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CTLT Catalent, Inc. Director $758K Oct 30, 2024
PTCT PTC THERAPEUTICS, INC. Director $539K Feb 15, 2024
CRNX Crinetics Pharmaceuticals, Inc. Director $446K -$812K -64.5% Jun 7, 2024
ALBO ALBIREO PHARMA, INC. Director Mar 2, 2023

Insider Transactions Reported by Stephanie Okey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.